A Japanese hospital said Monday it has completed a clinical test to transplant induced pluripotent stem cells that produce insulin to treat a patient with type 1 diabetes, in a step that could ease the burden of injecting daily insulin shots.
Kyoto University Hospital performed the surgery in February using iPS cell-derived pancreatic islet cells to confirm the safety of the procedure for the autoimmune disease, which prevents the pancreas from making insulin.
Read full story here